Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wheeler

Showing results (231-240 of 454) with videos related to

Pageof 46
Sort By:
Advances in Therapy|November 29, 2024
Baseline Characteristics of the DISCOVER CKD Prospective CohortCarol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 16, 2015
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney InjuryMatthew T James, Morgan E Grams, Mark Woodward, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J L Heerspink, Bergur V Stefansson, Glenn M Chertow, et al.
Journal of the American Heart Association|April 29, 2023
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD TrialGlenn M Chertow, Ricardo Correa-Rotter, Priya Vart, et al.
Nephrology (Carlton, Vic.)|August 24, 2020
Perspectives on blood pressure by patients on haemo- and peritoneal dialysisNicole Evangelidis, Benedicte Sautenet, Karine E Manera, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2023
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trialHiddo J L Heerspink, Peter J Greasley, Christine Ahlström, et al.
Kidney International|October 31, 2020
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancerCamillo Porta, Aristotelis Bamias, Farhad R Danesh, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
Journal of Nephrology|March 30, 2023
Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomesSunil Bhandari, Patrick Parfrey, Claire White, et al.
Advances in Therapy|February 3, 2025
Correction: Baseline Characteristics of the DISCOVER CKD Prospective CohortCarol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, et al.
Pageof 46

Showing results (231-240 of 454) with videos related to

Sort By:
Pageof 46
Advances in Therapy|November 29, 2024
Baseline Characteristics of the DISCOVER CKD Prospective CohortCarol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 16, 2015
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney InjuryMatthew T James, Morgan E Grams, Mark Woodward, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J L Heerspink, Bergur V Stefansson, Glenn M Chertow, et al.
Journal of the American Heart Association|April 29, 2023
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD TrialGlenn M Chertow, Ricardo Correa-Rotter, Priya Vart, et al.
Nephrology (Carlton, Vic.)|August 24, 2020
Perspectives on blood pressure by patients on haemo- and peritoneal dialysisNicole Evangelidis, Benedicte Sautenet, Karine E Manera, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2023
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trialHiddo J L Heerspink, Peter J Greasley, Christine Ahlström, et al.
Kidney International|October 31, 2020
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancerCamillo Porta, Aristotelis Bamias, Farhad R Danesh, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
Journal of Nephrology|March 30, 2023
Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomesSunil Bhandari, Patrick Parfrey, Claire White, et al.
Advances in Therapy|February 3, 2025
Correction: Baseline Characteristics of the DISCOVER CKD Prospective CohortCarol Pollock, Juan-Jesus Carrero, Eiichiro Kanda, et al.
Pageof 46